ACADIA Pharmaceuticals Inc. vs DENTSPLY SIRONA Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.06B), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.32B). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 2.2× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | XRAY | |
|---|---|---|
Market Cap | $5.06B | $2.32B |
Sector | Health | Health |
52-Week High | $29.41 | $14.68 |
52-Week Low | $20.06 | $9.64 |
Enterprise Value | $4.18B | $4.40B |
Dividend Yield | — | 5.04% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →